Document Type

Article

Publication Date

October 2023

Patent Number

11793177

CPC

A01K 67/0276

Abstract

The present invention concerns non-human animals with cells having a genome that is lacking the entire E3 ubiquitin ligase (Ube3a) gene (including all isoforms and alternative promoters). These animals are useful for modeling Angelman Syndrome. The invention also includes methods for assessing the effect of an agent, such as potential therapeutics, on an animal model by exposing the animal or cells, tissues, or organs isolated therefrom, to an agent of interest.

Application Number

16/330871

Assignees

UNIVERSITY OF SOUTH FLORIDA

Filing Date

10/03/2017

Share

COinS